BioGaia AB
- BID
10.93
- ASK
10.97
- 2,405 Units2,398 Units
- 07/21, 17:10:47 PM
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
21.85%
Market Cap
-
P/E Ratio
32.29
Dividend Yield
1.54 %
Earnings per Share
0.30 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 10.87 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 05:02:48 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 11 | 10.69 |
| PREV. DAY'S PRICE | 10.65 | (07/20) |
| CHANGE DAY BEFORE | +0.22 | 2.07 % |
| 52 WEEK HIGH / LOW | 12.54 (05/20) | 8.325 (08/18) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 0.32 | 0.30 | 0.30 | 0.36 | 0.42 |
DIVIDENDS PER SHARE | 0.17 | 0.17 | 0.15 | 0.38 | 0.43 |
DIVIDEND YIELD IN % | 1.88 % | 1.74 % | 1.54 % | - | - |
DIVIDEND GROWTH IN % | 21.10 % | 2.93 % | -12.93 % | - | - |
PRICE - EARNINGS RATIO | 27.97 | 32.19 | 32.29 | 31.80 | 26.70 |
PRICE - BOOK RATIO | 5.03 | 6.57 | 8.17 | - | - |
PRICE - SALES RATIO | 7.88 | 7.95 | 6.98 | - | - |
PRICE - CASH FLOW RATIO | 23.99 | 30.30 | 35.04 | - | - |
Master Data
| WKN | A3DL7T |
| ISIN | SE0017769995 |
| SYMBOL | BGLA |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Bio Gaia |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 1.24 % | 0.19 % | -6.25 % | 6.39 % | 21.85 % | 20.20 % | 14.27 % | 9.96 % |
| HIGH | 11.57 | 11.57 | 12.54 | 12.54 | 12.54 | 12.54 | 12.54 | 12.54 |
| LOW | 10.34 | 10.34 | 10.34 | 9.20 | 8.33 | 7.69 | 6.44 | 9.20 |
Dividende
pro Aktie
Company profile
BioGaia AB engages in the development, marketing, and sale of probiotic products. It operates through the following segments: Pediatrics, Adult Health, and Other. The Pediatrics segment sells drops, oral rehydration solutions, digestive health tablets, and also royalties pertaining to pediatric products. The Adult Health segment include gut health tablets, oral health products, and offers cultures as an ingredient in a licensee's dairy product. The Other segment consists royalties from the development projects, and revenue from packaging solutions. The company was founded by Jan Annwall and Peter Michael Rothschild in 1990 and is headquartered in Stockholm, Sweden.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.